On 13 February, the EU Polish Presidency, the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) jointly organised a webinar to present and discuss the ongoing development of the European Medicines Agencies Network Strategy (EMANS) to 2028. The webinar focused on the feedback received during the public consultation of the draft strategy, which took place from 9 October to 30 November 2024. EMA is currently reviewing this feedback and aims to adopt the final strategy by March 2025. The strategy, which aims to prepare the European medicines regulatory network to handle changes in the field of medicines regulation, highlights six key focus areas:
• Accessibility - facilitating access to medicines in the EU
• Leveraging data, digitalisation and artificial intelligence - improving decision-making, optimising processes and increasing efficiency
• Regulatory science, innovation and competitiveness - helping improve innovation and competitiveness in the EU healthcare sector
• Antimicrobial resistance and other health threats - preparing the EU for potential threats including antimicrobial resistance • Availability and supply - strengthening availability of medicines to protect public and animal health
• Sustainability of the European medicines agencies network - ensuring available resources to support its scientific and regulatory decision-making.
During the event, Marcin Kolakowski from the Polish Medicines Agency delivered the opening remarks, followed by an introduction to the strategy. Stakeholder feedback on each of the six themes was presented. Alzheimer Europe Project Officer Cindy Birck attended the webinar. A recording will be published after the event. For further details, visit the EMA event page:
https://www.ema.europa.eu/en/events/european-medicines-agencies-network-strategy-emans-2028-webinar